Literature DB >> 11882065

Riluzole and olanzapine in Huntington's disease.

Raphael M Bonelli, G Niederwieser, J Diez, P Költringer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11882065     DOI： 10.1046/j.1468-1331.2002.0354f.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN： 1351-5101            Impact factor:   6.089


× No keyword cloud information.
  3 in total

1.  Treatment of huntington disease.

Authors:  Aleksandar Videnovic
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

2.  Gait and Balance Dysfunction in Adults.

Authors:  Salil Manek; Mark F. Lew
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

3.  State-of-the-art pharmacological approaches to reduce chorea in Huntington's disease.

Authors:  Jessie S Gibson; Daniel O Claassen
Journal:  Expert Opin Pharmacother       Date:  2021-02-08       Impact factor: 4.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.